JP2020200325A - 牛蒡抽出物の使用 - Google Patents
牛蒡抽出物の使用 Download PDFInfo
- Publication number
- JP2020200325A JP2020200325A JP2020101370A JP2020101370A JP2020200325A JP 2020200325 A JP2020200325 A JP 2020200325A JP 2020101370 A JP2020101370 A JP 2020101370A JP 2020101370 A JP2020101370 A JP 2020101370A JP 2020200325 A JP2020200325 A JP 2020200325A
- Authority
- JP
- Japan
- Prior art keywords
- burdock
- extract
- burdock extract
- benign prostatic
- prostate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
大症と称され、中年の男性によくみられる疾患であり、頻尿(frequent urination)、排尿困難(trouble starting to urinate)、流量不足(weak stream)、尿路の中断(inability to urinate)又は、膀胱に対するコントロールの喪失(loss of bladder control
)といった症状が出ることがあり、更に尿路感染症(urinary tract infection)、膀胱
結石(bladder stones)及び慢性腎不全(chronic kidney problem)などの合併症(complication)が発症してしまうこともある。
抽出物は副作用を有しないが、ノコギリパルメット及びプルヌスアフリカナがアフリカ、大西洋及びカリブ海岸沿いにしか分布しないため、植物原料を手に入れることが難しく、コストも高まっている。これに鑑みて、依然として、良性前立腺肥大症を治療するための薬物を製造するのに用いられる牛蒡抽出物の使用を提供する必要がある。
に立つ効果を有する。牛蒡子は熟成した実であり、主な活性成分としてアルクチイン、及びアルクチデニンが含まれ、抗熱ショック、利尿の効果を有する。
例、第二実施例及び第三実施例の牛蒡抽出物はそれぞれ“牛蒡根抽出物”、“牛蒡葉抽出物”及び“牛蒡子抽出物”と称する。
組のBPHラットの前立腺重量に対して、牛蒡根抽出物、牛蒡葉抽出物及び牛蒡子抽出物をそれぞれ経口投与したA2組〜A4組のBPHラットの前立腺重量が明らかに減少し、それぞれ1.34±0.31g(P<0.05)、1.30±0.32g(P<0.05)及び0.93±0.14g(P<0.001)であり、本発明の牛蒡抽出物が良性前立腺肥大症を患った生物体の前立腺の重量を確実に縮減させることができることを示した。
Claims (4)
- 良性前立腺肥大症を治療するための薬物を製造するのに用いられる牛蒡抽出物の使用であって、前記牛蒡抽出物は水またはエタノール濃度が95%のエタノール水溶液である抽出剤により、牛蒡子試料を抽出して獲得するものであることを特徴とする牛蒡抽出物の使用。
- 前記牛蒡抽出物が、エタノール濃度が80〜98%のエタノール水溶液を抽出剤とし、牛蒡子試料を抽出して獲得するものであることを特徴とする請求項1に記載の牛蒡抽出物の使用。
- 前記牛蒡抽出物が需要個体に経口投与されることを特徴とする請求項1に記載の牛蒡抽出物の使用。
- 前記牛蒡抽出物の投与量は1日当たり、需要個体の体重1kgにつき900mgであり、28〜60日間連続して投与することを特徴とする請求項3に記載の牛蒡抽出物の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108120310A TWI693938B (zh) | 2019-06-12 | 2019-06-12 | 牛蒡萃取物的用途 |
TW108120310 | 2019-06-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020200325A true JP2020200325A (ja) | 2020-12-17 |
JP7139388B2 JP7139388B2 (ja) | 2022-09-20 |
Family
ID=71896143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020101370A Active JP7139388B2 (ja) | 2019-06-12 | 2020-06-11 | 良性前立腺肥大症を治療するための薬物を製造するのに用いられる牛蒡子抽出物の使用 |
Country Status (4)
Country | Link |
---|---|
US (1) | US11207364B2 (ja) |
JP (1) | JP7139388B2 (ja) |
CN (1) | CN112076238A (ja) |
TW (1) | TWI693938B (ja) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0570360A (ja) * | 1991-09-10 | 1993-03-23 | Lion Corp | 抗男性ホルモン剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1085097C (zh) * | 1999-10-26 | 2002-05-22 | 马俊杰 | 治疗前列腺增生的药物 |
US6428822B1 (en) * | 2001-04-03 | 2002-08-06 | Chengzhi Life Science Company, Ltd. | Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification |
US6790464B2 (en) * | 2003-01-16 | 2004-09-14 | Healthaid Enterprise Pte. Ltd. | Herbal compositions for prostate conditions |
CN101433568A (zh) * | 2008-12-19 | 2009-05-20 | 陈靠山 | 牛蒡根水提物的提取及应用 |
CN104491661B (zh) * | 2015-01-23 | 2017-08-29 | 湖南湘源美东医药科技有限公司 | 一种用于治疗前列腺炎或前列腺增生的中药组合物 |
TWI646967B (zh) * | 2017-11-08 | 2019-01-11 | 康力生技股份有限公司 | 牛蒡子萃取物的製備方法及純化方法 |
-
2019
- 2019-06-12 TW TW108120310A patent/TWI693938B/zh active
- 2019-08-13 CN CN201910745876.1A patent/CN112076238A/zh active Pending
-
2020
- 2020-06-10 US US16/897,423 patent/US11207364B2/en active Active
- 2020-06-11 JP JP2020101370A patent/JP7139388B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0570360A (ja) * | 1991-09-10 | 1993-03-23 | Lion Corp | 抗男性ホルモン剤 |
Also Published As
Publication number | Publication date |
---|---|
US11207364B2 (en) | 2021-12-28 |
TW202045199A (zh) | 2020-12-16 |
JP7139388B2 (ja) | 2022-09-20 |
TWI693938B (zh) | 2020-05-21 |
CN112076238A (zh) | 2020-12-15 |
US20200390839A1 (en) | 2020-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Al-Snafi | Chemical constituents and pharmacological effects of lepidium sativum | |
AU2017279694B2 (en) | Herbal Compositions for the Prevention or Treatment of Benign Prostatic Hyperplasia and Related Disorders | |
Caliskan et al. | Plants Used in Anatolian Traditional Medicine for the Treatment of Hemorrhoid. | |
Sharma et al. | A comprehensive review of the pharmacological actions of Asparagus racemosus | |
Lans et al. | Dr. Duke’s phytochemical and ethnobotanical databases, a cornerstone in the validation of ethnoveterinary medicinal plants, as demonstrated by data on pets in British Columbia | |
JP2001342142A (ja) | 泌尿器系疾患予防治療用組成物 | |
Boon et al. | The complete natural medicine guide to the 50 most common medicinal herbs | |
Lin et al. | Aqueous extract of Solanum nigrum attenuates Angiotensin-II induced cardiac hypertrophy and improves cardiac function by repressing protein kinase C-ζ to restore HSF2 deSUMOlyation and Mel-18-IGF-IIR signaling suppression | |
KR101432746B1 (ko) | 야콘, 사상자 및 석창포의 혼합 추출물, 이를 함유하는 탈모 또는 전립선 비대증의 예방 또는 개선용 건강식품 조성물 및 탈모의 예방 또는 개선용 화장료 조성물 | |
WO2004103387A1 (fr) | Utilisations des flavones de la feuille de bambou pour preparer des medicaments et des produits alimentaires hygieniques permettant de prevenir ou de traiter des maladies de la prostate | |
JP2020200325A (ja) | 牛蒡抽出物の使用 | |
Boddawar et al. | Assessment of anti-inflammatory potential of Sesbania bispinosa Linn. leaf extracts and fractions by acute and chronic models | |
El-Khatib et al. | Over-the-Counter Supplements and Men's Health | |
KR20220100809A (ko) | 단삼(Salvia miltiorrhiza Bunge) 추출물을 유효성분으로 포함하는 전립선비대증 또는 탈모증의 치료 또는 예방용 조성물 | |
KR20150037208A (ko) | 여성 폐경기 증후군 치료용 조성물 | |
TW200800242A (en) | Herbal compositions for the prevention or treatment of benign prostatic hyperplasia | |
George et al. | Acceptance of herbal medicines in andrology | |
WO2009135351A1 (zh) | 梅树提取物在制备组合物中的应用 | |
Huy et al. | Inhibition of calculi forming oxalate by dietary Basella rubra organs: Litholytic activity | |
Iweala et al. | Cytotoxic Assessment of Xylopia aethiopica [Dun.] A. on Human Prostate and Breast Cancer Cell Lines: doi. org/10.26538/tjnpr/v4i12. 18 | |
CN115919939B (zh) | 一种治疗乳腺增生的中药组合物及其制备方法与应用 | |
US20220370537A1 (en) | Pharmaceutical composition and functional health food for treating benign prostatic hyperplasia including laurus nobilis as active ingredient, and method of treating benign prostatic hyperplasia using the same | |
Berroukche et al. | Drugs and herbs in two divergent lines of benign prostatic hyperplasia therapy | |
Swati et al. | A critical review of potaki (Basella alba) in ayurvedic texts with recent studies | |
JP6871737B2 (ja) | ウロプラキン発現促進剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200619 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210615 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210915 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220118 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220418 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220823 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220907 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7139388 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |